Marex Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Buy
+1,007
New +$565K ﹤0.01% 683
2026
Q1
Sell
-350
Closed -$237K 1140
2025
Q4
$237K Buy
+350
New +$238K ﹤0.01% 791
2025
Q3
Sell
-577
Closed -$309K 923
2025
Q2
$309K Sell
577
-179
-24% -$85.6K ﹤0.01% 442
2025
Q1
$317K Sell
756
-275
-27% -$119K 0.01% 440
2024
Q4
$426K Buy
+1,031
New +$452K 0.01% 376
2024
Q3
Sell
-22,000
Closed -$10.7M 701
2024
Q2
$10.7M Buy
+22,000
New +$11M 0.29% 62

Other funds holding IDXX

Marex Group's IDXX Position: Q2 2026 in Review

Marex Group opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1,007 shares worth $530K. The stake represents ﹤0.01% of the portfolio and ranks #683 among its holdings. This is a return to the name: Marex Group previously reported a position in IDXX as recently as Q4 2025.

Marex Group first reported a position in IDXX in Q2 2024 and has held it in 6 quarters since. The position peaked at $10.7M in Q2 2024. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Marex Group held 1,007 shares of Idexx Laboratories worth $530K as of Q2 2026.
  • Idexx Laboratories was a new Marex Group position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #683 holding.
  • Marex Group first reported a position in Idexx Laboratories in Q2 2024 and has held it in 6 quarters since.
  • Marex Group's Idexx Laboratories position peaked at $10.7M in Q2 2024.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.